HYPOTENSIVE AND SEDATIVE EFFECTS OF α‐ADRENOCEPTOR AGONISTS: RELATIONSHIP TO α1‐AND α2‐ADRENOCEPTOR POTENCY
Open Access
- 19 July 1981
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 73 (3) , 595-604
- https://doi.org/10.1111/j.1476-5381.1981.tb16793.x
Abstract
1 The purpose of this study was to investigate whether the separation between the hypotensive and sedative effects of a new series of centrally acting antihypertensive drugs was due to differences between the relative pre-junctional (α2) and post-junctional (α1) adrenoceptor agonist properties of the compounds. 2 In anaesthetized rats the intravenous doses of clonidine, ICI 101187, ICI 106270, ICI 109683 and ICI 110802 required to lower blood pressure (BP) by 20 mmHg were 1.2, 5.1, 5.5, 3.3 and 5.4 μg/kg respectively. 3 In a test for sedation, ICI 101187 had at least 10 times less sedative effect than clonidine, ICI 106270 and ICI 109683 had at least 30 times less sedative effect than clonidine while ICI 110802 was not active. In a locomotor activity test the intravenous dose of clonidine required to reduce activity by 50% was 15.3 μg/kg, for ICI 101187 it was 194, for ICI 106270 it was 238 and for 110802 it was 313 μg/kg. 4 In the pithed rat the ED50s of clonidine, ICI 101187, ICI 106270, ICI 109683 and ICI 110802 as α2-agonists were 19.4, 9.3, 63.2, 43.0 and 78.5 μg/kg respectively. The α1-adrenoceptor potencies were quite similar for the five drugs and varied between 3.2 μg/kg for ICI 110802 and 8.7 μ/kg for ICI 106720. Potency as α2-adrenoceptor agonists was also assessed in the mouse vas deferens. Clonidine and ICI 101187 were similar in potency with IC50Ss of 9.3times 10−9M and 8.9 × l0−9M respectively. ICI 106270 and ICI 110802 were much weaker with IC50Ss of 4.9 × 10−8M and over 5.7 × 10_8M respectively. 5 Since all the compounds had similar potencies as α1-agonists, this could not explain their different sedative effects. The weakest compounds as sedatives were also weakest as α2-agonists, although ICI 101187 which was as potent as clonidine as an α2-agonist was still 10 times weaker as a sedative. 6 Hypotensive activity appears to be more closely related to α1- than to α2-potency. 7 Clonidine was more potent as both a sedative and a hypotensive agent than would be predicted from its activity at either the α1- or the α2-adrenoceptor.Keywords
This publication has 23 references indexed in Scilit:
- Presynaptic α-adrenoceptorsGeneral Pharmacology: The Vascular System, 1976
- Effects of α-adrenoceptor agonists and antagonists on pre- and postsynaptically located α-adrenoceptorsEuropean Journal of Pharmacology, 1976
- Pre- and postsynaptic components in effect of drugs with α adrenoceptor affinityNature, 1975
- Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbineEuropean Journal of Pharmacology, 1974
- Presynaptic regulation of catecholamine releaseBiochemical Pharmacology, 1974
- Evidence for direct α-adrenoceptor stimulation of effector neurons in cardiovascular centers by clonidineEuropean Journal of Pharmacology, 1974
- Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: Antagonism by piperoxaneEuropean Journal of Pharmacology, 1971
- Sedative effects of α-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugsEuropean Journal of Pharmacology, 1971
- A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and ratBritish Journal of Pharmacology, 1970